Free public records show Pharmobedient in 18 of the markets we cover. It is not a key player in our research.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
88 approvals with a product on the US market
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.
Markets we cover where free public records show Pharmobedient: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Pharmobedient is in.
Stories on the topics Pharmobedient works in.
Seasonal flu causes about a billion cases a year. Vitamin C and zinc can shorten colds a little, but vaccines…
Read
Omega-3 supplements are hugely popular. Big trials give mixed answers on whether they protect the heart.
Read
TB killed 1.23 million people in 2024. WHO now recommends rapid molecular tests first, bringing lab-grade…
Read